Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Insights Into Submissions and Medical Journal Publications in Korea.
J Korean Med Sci
January 2025
Division of Infectious Diseases, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
We analyzed the publication and submission statuses of Korean medical journals from 2010 to 2024, amidst challenges impacting researchers. Data from 58 domestic journals identified through the 2023 JCR database were used to assess publication status, while data from the () were utilized to examine submission status. The proportion of published original articles by domestic authors decreased by 3% in 2024 compared to 2023.
View Article and Find Full Text PDFDepression in the COVID-19 endemic era: Analysis of online self-disclosures by young South Koreans.
PLoS One
December 2024
Department of Psychology, Yonsei University, Seoul, Republic of Korea.
Although COVID-19 has been declared endemic in South Korea, there are economic and psychosocial after-effects. One of these is the prevalence of depression. Depressed adolescents and young adults struggle with insecurity, loneliness, and lack of confidence due to the life limitations imposed during the pandemic.
View Article and Find Full Text PDFSeroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: A serial cross-sectional study.
PLoS One
December 2024
University of California, San Francisco, CA, United States of America.
Background: Understanding COVID-19's impact on children is vital for public health policy, yet age-specific data is scarce, especially in Uganda. This study examines SARS-CoV-2 seroprevalence and risk factors among Ugandan children at two timepoints, along with COVID-19-related knowledge and practices in households, including adult vaccination status.
Methods: Baseline surveys were conducted in 12 communities from April to May 2021 (post-Alpha wave) and follow-up surveys in 32 communities from November 2021 to March 2022 (Omicron wave).
Beyond Antivirals: Alternative Therapies for Long COVID.
Viruses
November 2024
Department of Medicine, University of Patras, 26504 Rio, Greece.
Long COVID or Post-Acute Sequelae of SARS-CoV-2 infection (PASC) is a condition characterized by numerous lingering symptoms that persist for weeks to months following the viral illness. While treatment for PASC is still evolving, several therapeutic approaches beyond traditional antiviral therapies are being investigated, such as immune-modulating agents, anti-inflammatory drugs, and various supportive interventions focusing at alleviating symptoms and enhancing recovery. We aimed to summarize the breadth of available evidence, identify knowledge gaps, and highlight promising non-antiviral therapies for Long COVID/PASC.
View Article and Find Full Text PDFPulmonary actinomycosis complicating COVID-19 pneumonia in an immunocompetent patient: a case report.
Future Sci OA
December 2024
Pulmonology Department, Mohamed Taher Maamouri University Hospital Nabeul University of Tunis El Manar, Nabeul, Tunisia.
Article Synopsis
- - A case study reports a 48-year-old male smoker who developed pyopneumothorax after experiencing pneumonia caused by COVID-19, requiring oxygen support and antibiotic treatment.
- - After initial recovery, he experienced hemoptysis, leading to a diagnosis of actinomycosis through endoscopic biopsy histopathology.
- - The patient responded well to prolonged antibiotic therapy with amoxicillin, highlighting the need to consider pulmonary actinomycosis in patients displaying lasting respiratory symptoms post-COVID-19.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!